Status | Study |
Completed |
Study Name: Study of the Progression of Bacterial Conjunctivitis Symptoms Upon Antibiotic Treatment Condition: Bacterial Conjunctivitis Date: 2008-11-25 Interventions: Drug: Vigamox Ophthalmic Solution |
Completed |
Study Name: Moxifloxacin AF Ophthalmic Solution for Treatment of Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2008-09-23 Interventions: Drug: Moxifloxacin eye drops e |
Completed |
Study Name: Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2008-02-14 Interventions: Drug: ISV-403 0.6% TID, 5 days |
Completed |
Study Name: Study of Efficacy of Levofloxacin 0.5% Ophthalmic Solution Administered Three Times a Day for Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2007-11-27 Interventions: Drug: 0.5% levofloxacin eye drops |
Completed |
Study Name: A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2007-08-16 Interventions: Drug: Gatifloxacin 0.5% eye drops |
Completed |
Study Name: Systemic Pharmacokinetics of BOL-303224-A Condition: Conjunctivitis, Bacterial Date: 2006-12-01 Interventions: Drug: BOL-303224-A 1 drop in each eye, TID for 5 days at approximately 6 h intervals, with a final, sing |
Completed |
Study Name: Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis Condition: Conjunctivitis, Bacterial Date: 2006-07-25 Interventions: Drug: Azithromycin (T1225) |
Completed |
Study Name: A Study to Determine if 0.6% ISV-403 is Safe and Effective in the Treatment of Bacterial Conjunctivitis. Condition: Acute Bacterial Conjunctivitis Date: 2006-06-30 Interventions: Drug: ISV-403 Subjects with ba |
Completed |
Study Name: A Study to Investigate the Safety and Efficacy of BOL-303224 in the Treatment of Bacterial Conjunctivitis Condition: Acute Bacterial Conjunctivitis Date: 2006-06-30 Interventions: Drug: Besifloxacin Besifloxaci |
Completed |
Study Name: AL-15469A for the Treatment of Bacterial Conjunctivitis Condition: Bacterial Conjunctivitis Date: 2006-05-30 Interventions: Drug: Moxifloxacin Alternative Formulation Ophthalmic Solution 0.5% |